Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo. - Wikidata - wikimedia - TriplyDB

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

http://www.wikidata.org/entity/Q37151837

about

Stabilization of high-risk plaques Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL New Era of Lipid-Lowering Drugs Egg phospholipids and cardiovascular health The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects HDL-apoA-I exchange: rapid detection and association with atherosclerosis Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis.Impact of self-association on function of apolipoprotein A-I Novel HDL-directed pharmacotherapeutic strategies.The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy.Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans Targeting high density lipoproteins in the prevention of cardiovascular disease?HDL, Atherosclerosis, and Emerging Therapies An abundant dysfunctional apolipoprotein A1 in human atheroma.ABC transporters, atherosclerosis and inflammation.Current guidelines for high-density lipoprotein cholesterol in therapy and future directions.Implications of torcetrapib failure for the future of HDL therapy: is HDL-cholesterol the right target?Update on HDL receptors and cellular cholesterol transport.New lipid-lowering drugs: an update.Thyroid hormone enhances the ability of serum to accept cellular cholesterol via the ABCA1 transporter.Underappreciated opportunities for high-density lipoprotein particles in risk stratification and potential targets of therapy.ApoA-I-Directed Therapies for the Management of Atherosclerosis.Apolipoprotein A-I: A Molecule of Diverse Function.High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.High-density lipoprotein subpopulation profiles in lipoprotein lipase and hepatic lipase deficiency.Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport.Evaluation of HDL-modulating interventions for cardiovascular risk reduction using a systems pharmacology approach.High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol.

P2860

Q26738584-B4E8B67A-13C0-4DEE-9BEF-7667F49F0B48 Q26801507-3864C73F-7066-4BC0-BB96-730DD52E6C62 Q28072298-FD7FF399-946D-4D26-8C7D-3606B91B63B6 Q28082796-41225B08-A06B-40EB-AC30-8B1D25034F5F Q28388695-08633CEB-D911-49B2-ACF3-EAAC9896E043 Q28535779-E7FC23EF-504E-4A3A-AC2C-60B5E271B2AF Q33675617-317991B0-7F0B-44EC-A58A-5E426104BA10 Q33897950-1462FFA1-82FA-4CAF-8966-D658EDC6740B Q34155049-09057B70-0AB9-4766-B505-82E23BA98DEF Q34781496-0D247F89-DBDC-4631-BB4B-54CA5E513FD9 Q35371440-2FED9358-520C-435E-8BCD-7576C214ADF6 Q35860020-A02D042F-32C7-45AA-B84D-534E087402DE Q36109412-8591FBC4-5839-47CF-A306-29B2AA4D0F76 Q36403156-3F7F2D78-2843-41F5-BD60-D855C6B14240 Q36453173-981F42FE-3D32-438E-936B-29F5D412854A Q36918309-2B26594A-D19F-4D6D-A2C4-297B0DE2AB1B Q37581580-DCB86291-AB75-4092-95B7-3D1EC91F9D01 Q37688500-359661F5-8DC8-4083-B0DA-F3AD89A947B5 Q37702199-E8ACEC4D-F1C6-4562-AA2C-D91D4D3960DB Q37707402-351EB707-BFC4-4AC5-BDC7-ABCD25498F45 Q37837679-32834D07-B722-4A98-B21D-E00A36C4E997 Q37984782-4DA44EBF-761C-4DEA-9116-3C24FE2830DC Q38334939-90695823-0232-4B60-8179-FA42E563A50C Q38363617-5C76057B-BC49-4FFE-839B-8CB4EECDBBF3 Q38579703-EA941908-43EC-48A8-9E80-7C10D56F5293 Q38844884-18FAEE32-CD68-453C-B7E0-B7FDB27E8950 Q38965138-7989246A-BA0C-4D51-AF53-E0076E59D01C Q39442094-BB14D807-8FC1-4453-9B76-02BB20CCB7E3 Q42126715-5C129BE7-2E52-4ECE-88A6-9F5C4B26E257 Q42131230-A5484563-80EA-4CCA-B401-960B5DC3FF49 Q45870343-A61DC9F6-BBF0-4F7C-BE8D-44B8443D03C8

P2860

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

http://www.wikidata.org/entity/Q37151837

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@en

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@nl

type

label

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@en

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@nl

prefLabel

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@en

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@nl

P1433

Q37151837-2E5DE286-263E-45B2-B0B2-C8A3D4A1FF9F

P1476

Q37151837-1E649405-0ED6-46EB-8C20-04C6091E25DA

P2093

Q37151837-0D438A61-A1A7-4D1A-B36B-CDFFC334C804

Q37151837-1944E7FA-4554-4351-9A3D-93260EE05705

Q37151837-1DEDA1DB-4BBF-4409-B559-0BFFBB9871A0

Q37151837-2CB844D4-1259-4E8A-A97C-D88FE991AD69

Q37151837-3A8CD213-8FEC-4681-9C11-CA2D2783DAB9

Q37151837-3B70A624-20C8-4A3B-AFE0-54358906A567

Q37151837-3C3E823A-4769-402D-BC97-7C9D88935E7B

Q37151837-45A1E5D3-FA6F-4587-884F-1DCE1C89AEE2

Q37151837-4D646EE7-893C-495F-811F-420D4374B39A

Q37151837-57F1E3CA-EF86-4752-9AC5-2EC0DF1A6196

P2860

Q37151837-00C360AE-2B55-4F0C-9748-33609313312F

Q37151837-15B07220-6A1C-4620-9B9A-2C2173BB8F36

Q37151837-1B934CCD-644F-4023-A1B9-950740EFFBF5

Q37151837-2B47835F-5995-4659-86F4-CA0BFD5F1074

Q37151837-332DED5D-2A60-4747-B0B3-0CE36AB4E0ED

Q37151837-348B7006-EEF6-4C4B-AD31-CC84859AE735

Q37151837-373C6FB8-6667-459E-AAED-4186CB544FE0

Q37151837-377DA1C6-DA25-488E-8EEE-16AE3641B608

Q37151837-4117B9EF-7F31-4021-B60C-3AE9FCD74583

Q37151837-41C5CBEB-83C7-4774-A9AA-80317012BFAF

P304

Q37151837-2A65E21F-F2A5-430B-B1E5-4FF7AED1D3E2

P31

Q37151837-7581BB1D-3796-4510-BDE9-244109CD9723

P356

Q37151837-AE9E747D-0657-47AB-B6C8-2F6D24B3B789

P433

Q37151837-5CF135A4-F4E8-495B-A7CB-5FBC90583DF3

P478

Q37151837-BD71A5CB-F9B1-4AE1-8BF1-AD8661943006

P577

Q37151837-EFC37474-A391-4EC5-BBB2-A398E2BE687C

P698

Q37151837-BD657117-341A-4925-B5A0-2342E7E0F3E4

P932

Q37151837-59C64DAB-6579-4370-8C22-1C1A2CC9DBEC

P356

JLR.M800622-JLR200

P1433

Journal of Lipid Research

P1476

Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

@en

P2093

Adam Conner

http://www.w3.org/2001/XMLSchema#string

Bela Asztalos

http://www.w3.org/2001/XMLSchema#string

Chunyu Zheng

http://www.w3.org/2001/XMLSchema#string

Frank M Sacks

http://www.w3.org/2001/XMLSchema#string

George Rothblat

http://www.w3.org/2001/XMLSchema#string

Gerhard Kostner

http://www.w3.org/2001/XMLSchema#string

H Bryan Brewer

http://www.w3.org/2001/XMLSchema#string

Hassibullah Akeefe

http://www.w3.org/2001/XMLSchema#string

Jo-Ann B Maltais

http://www.w3.org/2001/XMLSchema#string

Lawrence L Rudel

http://www.w3.org/2001/XMLSchema#string

P2860

The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

Variations on a gene: rare and common variants in ABCA1 and their impact on HDL cholesterol levels and atherosclerosis

ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Cell cholesterol efflux: integration of old and new observations provides new insights.

The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice

Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men.

American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consen

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

P304

894-907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M800622-JLR200

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19144994

http://www.w3.org/2001/XMLSchema#string

P932

2666176

http://www.w3.org/2001/XMLSchema#string